Inhibition of the NLRP3 inflammasome using MCC950 reduces vincristine-induced adverse effects in an acute lymphoblastic leukemia patient-derived xenograft model. - Starobova H; McCalmont H; Shatunova S; Tay N; Smith CM; Robertson A; Winkler I; Lock RB; Vetter I (HemaSphere, 2025)